Journal article
Intravenous milrinone for delayed cerebral ischaemia in aneurysmal subarachnoid haemorrhage: a systematic review
Abstract
BACKGROUND: Aneurysmal subarachnoid haemorrhage (aSAH) is a major contributor to mortality worldwide, with delayed cerebral ischaemia (DCI) contributing significantly to morbidity in these patients. There are limited evidence-based therapies for DCI. A 2012 case series first recommended the use of intravenous (IV) milrinone in this patient population, stating the need for formal prospective trials. However, uptake of this therapy into clinical …
Authors
Lannon M; Martyniuk A; Sharma S
Journal
British Journal of Neurosurgery, Vol. 38, No. 5, pp. 1120–1125
Publisher
Taylor & Francis
Publication Date
10 2024
DOI
10.1080/02688697.2022.2125160
ISSN
0268-8697